Dynamic molecular and histopathological changes in the extracellular matrix and inflammation in the transition to heart failure in isolated volume overload

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 6, 2011, Pages

  Chen, Yuan wen ^a,d   Pat, Betty ^a   Gladden, James D ^a   Zheng, Junying ^a   Powell, Pamela ^a   Wei, Chih Chang ^a   Cui, Xiangqin ^b   Husain, Ahsan ^e   Dell'Italia, Louis J ^a,c  

^a Center for Heart Failure Research   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Department of Veteran Affairs ^*  (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioenergetics; Congestive heart failure; Energy metabolism; Gene expression; Growth factors cytokines; Microarray; Peroxisome proliferator activated receptor

Indexed keywords

AMINO ACID; COLLAGEN; FATTY ACID; GLUCOSE; MITOCHONDRIAL ENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; APOPTOSIS; ARTICLE; BIOENERGY; CELL CYCLE; CELL INFILTRATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENERGY METABOLISM; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; GENE EXPRESSION; GLUCOSE METABOLISM; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RNA ISOLATION; UPREGULATION; VASODILATATION;

ANIMALS; CELL ADHESION MOLECULES; DISEASE PROGRESSION; ENERGY METABOLISM; EXTRACELLULAR MATRIX; HEART FAILURE; HEMODYNAMICS; INFLAMMATION; MALE; MODELS, ANIMAL; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79958029159     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01104.2010     Document Type: Article

References (36)

1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300, 1995.
2. Borer JS, Bonow RO. title typecontributorContemporary approach to aortic and mitral regurgitation/title. Circulation 108: 2432-2438, 2003.
3. Borg T, Markwald. Periostin: more than just an adhesion molecule. Circ Res 101: 230-231, 2007.
4. Brower GL, Chancey AL, Thanigaraj S, Matsubara BB, Janicki JS. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol 283: H518-H525, 2002.
5. Chancey AL, Brower GL, Peterson JT, Janicki JS. Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. Circulation 105: 1983-1988, 2002.
6. Chandrashakhar Y. Embracing diversity in remodeling: a step in therapeutic decision making in heart failure? J Am Coll Cardiol 49: 822-825, 2007.
7. Chen Y, Pat B, Zheng J, Cain L, Powell P, Shi K, Sabri A, Husain A, Dell'Italia LJ. Tumor necrosis factor- produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload. J Mol Cell Cardiol 49: 70-78, 2010.
8. Conway SJ, Molkentin JD. Periostin as a heterofunctional regulator of cardiac development and disease. Curr Genomics 9: 548-555, 2008.
9. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4: P3, 2003.
10. Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 48: 504-511, 2010.
11. Dolgilevich SM, Siri FM, Atlas SA, Eng C. Changes in collagenase and collagen gene expression after induction of aortocaval fistula in rats. Am J Physiol Heart Circ Physiol 281: H207-H214, 2001.
12. Feingold K, Kim MS, Shigenaga J, Moser A, Grunfeld C. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am J Physiol Endocrinol Metab 286: E201-E207, 2004.
13. Feingold KR, Wang Y, Moser A, Shigenaga JK, Grunfeld C. LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney. J Lipid Res 49: 2179-2187, 2008.
14. Hamilton DW. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal 2: 9-17, 2008.
15. Hittinger L, Shannon RP, Bishop SP, Gelpi RJ, Vatner SF SF. Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res 65: 971-980, 1989.
16. Jobe LJ, Meléndez GC, Levick SP, Du Y, Brower GL, Janicki JS. TNF-α inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol 297: H1462-H1468, 2009.
17. Katsuragi N, Morishita R, Nakamura N, Ochiai T, Taniyama Y, Hasegawa Y, Kawashima K, Kaneda Y, Ogihara T, Sugimura K. Periostin as a novel factor responsible for ventricular dilation. Circulation 110: 1806-1813, 2004.
18. Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, Feingold KR. Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPAR γ, LXRα, and the coactivators SRC-1, PGC-1 γ, and PGC-1 in liver cells. Metabolism 56: 267-279, 2007.
19. Kolpakov MA, Seqqat R, Rafiq K, Xi H, Margulies KB, Libonati JR, Powel P, Houser SR, Dell'Italia LJ, Sabri A. Pleiotropic effects of neutrophils on myocyte apoptosis and left ventricular remodeling during early volume overload. J Mol Cell Cardiol 47: 634-645, 2009.
20. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43: 739-745, 2004.
21. Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol Endocrinol Metab 274: E210-E217, 1998.
22. Nemoto S, Razeghi P, Ishiyama M, De Freitas G, Taegtmeyer H, Carabello BA. PPAR- γ agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation. Am J Physiol Heart Circ Physiol 288: H77-H82, 2005.
23. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 2nd, Conway SJ, Aronow BJ, Robbins J, Molkentin JD. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101: 313-321, 2007.
24. Olivetti G, Capasso JM, Sonnenblick EH. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res 67: 23-34, 1990.
25. Pellieux C, Montessuit C, Papageorgiou I, Lerch R. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-α. Cardiovasc Res 82: 341-350, 2009.
26. Planavila A, Calvo RR, Vazquez-Carrera M. Peroxisome proliferatoractivated receptors and the control of fatty acid oxidation in cardiac hypertrophy. Mini Rev Med Chem 6: 357-363, 2007.
27. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA, Dell'Italia LJ. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49: 811-821, 2007.
28. Ruzicka M, Keeley FW, Leenen FH. The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin. Circulation 90: 1989-1996, 1994.
29. Sabri A, Rafiq K, Seqqat R, Kolpakov MA, Dillon R, Dell'Italia LJ. Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog. Circ Res 102: 1127-1136, 2008.
30. Sekiguchi K, Tian Q, Ishiyama M, Burchfield J, Gao F, Mann DL, Barger PM. Inhibition of PPAR-α activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF- /Smad3. Am J Physiol Heart Circ Physiol 292: H1443-H1451, 2007.
31. Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S, Saga Y, Fukayama M, Sata M, Kudo A. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205: 295-303, 2008.
32. Smeets PJH, de Vogel-van den Bosch HM, Willemsen PHM, Stassen AP, Ayoubi T, van der Vusse GJ, van Bilsen M. Tanscriptome analysis of PPAR α-dependent alterations during cardiac hypertrophy. Physiol Genomics 36: 15-33, 2008.
33. Smeets PJ, Planavila A, van der Vusse GJ, van Bilsen M. Peroxisome proliferator-activated receptors and inflammation: take it to heart. Acta Physiol (Oxf) 191: 171-188, 2007.
34. Wagner RA, Tabibiazar R, Powers J, Bernstein D, Quertermous T. Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses. J Mol Cell Cardiol 37: 1159-1170, 2004.
35. Weber KT. From inflammation to fibrosis: a stiff stretch of highway. Hypertension 43: 716-719, 2004.
36. Zheng J, Chen Y, Pat B, Dell'Italia LA, Tillson M, Dillon AR, Powell PC, Shi K, Shah N, Denney T, Husain A, Dell'Italia LJ. Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog. Circulation 119: 2086-2095, 2009.